Pegalin ER 165 mg (Tablet (Extended Release))

Unit Price: ৳ 35.00 (3 x 10: ৳ 1,050.00)
Strip Price: ৳ 350.00

Medicine Details

Indications

  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury

Pharmacology

  • Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
  • Binds with high affinity to the alpha2-delta site in central nervous system tissues
  • Mechanism of action not fully elucidated
  • Results in animal studies suggest anti-nociceptive and antiseizure effects

Dosage

  • Maximum recommended dose for diabetic peripheral neuropathy: 100 mg three times a day
  • Maximum recommended dose for postherpetic neuralgia: 75 to 150 mg two times a day or 50 to 100 mg three times a day
  • Recommended dose for fibromyalgia: 300 to 450 mg/day
  • Recommended dose range for neuropathic pain associated with spinal cord injury: 150 to 600 mg/day
  • Dosage form conversion guidance
  • Pregabalin tablet total daily dose vs Pregabalin CR capsule dose

Administration

  • Route of administration: Oral, with or without food
  • Pregabalin CR tablet administration after an evening meal
  • Guidance on missed doses and discontinuation

Interaction

  • Unlikely to be involved in significant pharmacokinetic drug interactions
  • No significant drug interaction with food and others

Contraindications

  • Contraindicated in patients with known hypersensitivity to Pregabalin or any of its components

Side Effects

  • Common side effects in adults: dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, thinking abnormal
  • Common side effects in pediatric patients for the treatment of partial onset seizures: increased weight and increased appetite

Pregnancy & Lactation

  • No adequate and well-controlled studies in pregnant women
  • Potential risk to fetus
  • Small amounts detected in the milk of lactating women
  • Breastfeeding not recommended

Precautions & Warnings

  • Potential occurrence of angioedema
  • Discontinuation and monitoring in case of hypersensitivity reactions
  • Increased risk of suicidal thoughts or behavior
  • Possible respiratory depression when used with concomitant CNS depressants or in the setting of underlying respiratory impairment
  • Potential to cause dizziness, somnolence, and impaired ability to drive or operate machinery
  • Need for gradual withdrawal over a minimum of 1 week

Use in Special Populations

  • Safety and effectiveness not established in pediatric patients for certain indications

Overdose Effects

  • Signs and symptoms of overdose
  • No specific antidote
  • General supportive care indicated, including monitoring of vital signs

Therapeutic Class

  • Adjunct anti-epileptic drugs
  • Primary anti-epileptic drugs

Storage Conditions

  • Keep in a cool & dry place (below 30°C)
  • Protected from light & moisture
  • Keep out of the reach of children

Chemical Structure

  • Molecular Formula: C8H17NO2
  • Chemical Structure image available

Common Questions about Pegalin ER 165 mg Tablet

  • Description of the medication
  • Duration required to see improvement in condition
  • Frequency of usage
  • Instructions for storage and disposal
  • Varied mechanisms of action for different diseases

Related Brands